AMSTERDAM and CHICAGO, Nov. 27, 2017 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled the IQon Elite Spectral CT to provide clinicians with ...

Reinforcing its commitment to enabling confident diagnosis through innovation, Royal Philips (NYSE: PHG AEX: PHIA) today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

MARKHAM, Ontario--(BUSINESS WIRE)--Royal Philips (NYSE:PHG, AEX:PHIA), a leading health technology company, today announced the launch of the Philips IQon Spectral CT in Canada. The Philips IQon ...

The FINANCIAL — Royal Philips on May 4 announced the installation of its IQon Spectral CT, the industry’s first spectral detector-based Computed Tomography (CT) at the University Medical Center ...

Due to its accessibility, speed and assessment capabilities, CT imaging is widely used in the diagnosis of many different diseases and injuries. By providing spectral capabilities within traditional ...

"Unlike traditional CT images, which can be limited in structural detail and require additional scans, Philips' IQon Spectral CT allows our clinicians to identify the composition of materials in the ...

Closing in on the medical imaging and healthcare informatics space, Philips ($PHG) has snagged premarketing approval in the U.S. for its IQon Spectral CT, which ...

Developed in collaboration with leading clinicians, Philips' Vereos digital PET/CT system and IQon Spectral CT system[1] are designed to create a short path to the best care and help improve patient ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advance in radiation oncology with 510(k) clearance from the US Food ...

ANDOVER, Mass., Nov. 25, 2014 /PRNewswire/ -- Reinforcing its commitment to enabling confident diagnosis through innovation, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug ...